GAIL S. PRINS, Ph.D.

 

PRESENT ADDRESS:Department of Urology

University of Illinois at Chicago

820 South Wood Street, M/C 955

Chicago, IL  60612

312-413-9766 (phone); 312-996-1291 (FAX)

gprins@uic.edu

 

EDUCATIONAL BACKGROUND:

1970 - 1974               B.A. in Biology/Chemistry, summa cum laude

Trinity Christian College, Palos Heights, IL

 

1974 - 1979               Ph.D. in Physiology

Department of Physiology and Biophysics

University of Illinois Medical Center, Chicago, IL

 

1979-83         Postgraduate: NIH  Postdoctoral Fellow

Depart­ment of Urology and Center for Reproduc­tive Science

Northwes­te­rn University Medical School, Chicago, IL

 

ACADEMIC AND PROFESSIONAL POSITIONS:

2001-present Professor of Physiology (tenured), Departments of Urology and Physiol­ogy & Biophysics, College of Medicine, University of Illinois at Chicago

1996-2001     Associate Professor of Physiology (tenured), Departments of Urology, Obstetrics & Gynecology, Physiology & Biophysics, University of Illinois

1996-present Director, University Andrology Laboratory, Department of Urology;

IVF Laboratory Consultant, Department of Obstetrics & Gynecology, University of Illinois

1997-present Full Member, Graduate Faculty, University of Illinois Graduate College

1990-1995     Research Associate Professor, Department of Obstetrics & Gynecol­ogy, University of Illinois at Chicago

1983-1990     Assistant Professor, Department of Obstetrics and Gyneco­logy,

Pritzker School of Medicine, University of Chicago

1983-1995     Attending Scientific Staff, Michael Reese Hospital, Department of Obstetrics & Gyne­cology, Division of Repro­ductive Endocrinolo­gy

1987-1995     Director, Reproductive Biology Laboratory,

Michael Reese Hospital & Medical Center

1983-87         Director, University of Chicago-Michael Reese Hospital

In Vitro Fertilization Laboratory and Andrology Laboratory

 

AWARDS:

2001   Distinguished Service Award, American Society of Andrology

1985   Martin R. Rosenthal Memorial Research Award, Michael Reese Hospital Research and Education Foundation

1980-82 NIH  Individual Research Fellowship Award (NRSA)     

1975   Graduate Research Program Award, Argonne National Laboratory

1973   VanderVelde Award for Academic Achievement, Trinity Chris­tian College

 

GRANTS:

1989-05 National Institutes of Health, NIDDK,  Principal Investigator  “Developmental Estrogenizati­on of the Rat Prostate Gland",  R01 DK40890-15

2003-06                  National Institutes of Health, NIEHS,  Principal Investigator, “Estrogen imprinting of the prostate gland via gene methylation”, R21 ES12282

2004-08 National Institutes of Health, NCI, Co-Investigator (PI: A. Diamond, Ph.D.), “Selenoproteins and Prostate Cancer”  R01 CA101053

2003-06 Department of Defense, Co-Investigator  (PI: S. Swanson, PhD), “Role of Growth Hormone in Prostate Cancer”

2002-07 National Institute of Health, NIEHS, Co-Investigator (PI: F. vom Saal, PhD),

“Developmental Toxicity of Environmental Chemicals”, R01 ES11283 

2004-06 American Foundation of Urologic Disease Research Fellowship (on behalf of Dr. Liwei Huang), “ The Role of Growth Hormone in Prostate Cancer”

2004-05 American Cancer Society,   Co-PI (PI: D. Hales, PhD), “CYP1B1 and oxidative stress: markers for prostate disease”

2002-03 National Institute of Health, NIA,  Co-Investigator (PI: S. Swanson, PhD), “Role of Growth Hormone in Prostate Cancer: Rodent Models”, R03 AG 20820

1998-01 Environmental Protection Agency, STAR Award,  Principal Investigator,  “Effects of early exposure to xenoestrogens on the prostate gland”, R826299

1999-01 National Institutes of Health, NCI, “Preclinical Toxicology of Chemopreventive Agents: Evaluation of Hydrogen Ion Concentration in Prostates from Rats and Dogs”, Co-Investigator (PI: A. Levine, Ph.D.), N01-CN-95055

1997-01 NRSA Predoctoral Research Fellowship (on behalf of Carl A Woodham), “Mechanism of prostatic androgen receptor regulation by neonatal estrogens”

1998-00 American Foundation of Urologic Disease Research Fellowship (on behalf of Dr. William Chang), “Retinoic acid  receptors in estrogenized rat prostate”

1998-00 NRSA Postdoctoral Research Fellowship, NIH  (on behalf of Dr. William Chang), “Retinoic acid receptors in estrogenized rat prostate” F32 DK09873

1992-95 Research and Education Foundation Grant, Michael Reese Hospital,   Principal Investigator, "Prostate cancer androgen receptor by immunocytochemistry",

1991-92 Medical Research Institute Council, Michael Reese Hospital, Principal Investigator,  "Neonatal and prepubertal imprinting of the adult prostate gland",

1988-90 American Cancer Society,   Principal Investigator, "Hormonal regulation of prostate steroid receptors",  Grant # PDT-358

1985-87 Michael Reese Medical Research Institute, Principal Investigator, "Prolactin testoster­one synergism in regulating growth of the prostate: prolactin's effect on the androgen receptor system",  BRSG S07 RR 054476

1980-82 NRSA Individual Research Fellowship, National Institutes of Health, "Prolactin-testosterone synergism in the rat prostate gland", F32 HD06175

 

 

PROFESSIONAL SOCIETY MEMBERSHIPS:

Endocrine Society, American Society of Andrology, Society for the Study of Reproduction,

Society for Basic Urologic Research, Society for Developmental Biology,

American Association of Anatomists, American Society of Reproductive Medicine

American Urologic Association, American Association of Bioanalysts

American Association of Tissue Banks, American Association for the Advancement of Science

 

COMMITTEES:

INTRAMURAL:

2002-04 Academic Freedom and Tenure Committee, UIC Senate

2000-05 CME Committee, College of Medicine

2000-05 Academic Affairs Committee, College of Medicine

1999-02            Faculty Senate, UIC

2000-02 Senate Faculty Affairs Committee

2000-02 Senate Research Committee

1998-03 Admissions Committee, MD/PhD Training Program, UIC

2001-04 Teaching Awards Selection Committee, University of Illinois College of Medicine

1998-02            Committee on Research, University of Illinois College of Medicine

1998-99            Search Committee, Head of Biochemistry & Molecular Biology, UIC

1997-98            Search Committee, Head of Obstetrics & Gynecology, UIC

1995-98 Steering Committee, Prostate Cancer Program, University of Chicago

1990-96 Institutional Animal Care and Use Committee, MRH

1988-96 Institutional Research Committee, MRH

1995-96 Research Radioisotope Committee, MRH

1990-92 Committee on Re­search, University of Illinois College of Medicine

1988-92 Institutional Review Board, MRH

EXTRAMURAL:

2003-05 Chair, Development Committee, American Society of Andrology

2000-03 Chair, Membership Committee, Society for Basic Urologic Research

2003-04 Development Committee, Society for the Study of Reproduction

1999-03            Chair, Finance Committee, American Society of Andrology

2000-03 Associates Committee, The Endocrine Society

2001-02 Awards Committee, Society for the Study of Reproduction

1998-01            By-Laws Committee, American Association of Tissue Banks

1999-03 Program Committee, American Society of Andrology

1997-02 Steering Committee, Chicago Prostate Consortium

1997-00            Membership Committee, Society for Basic Urologic Research

1996-97            Liaison Committee for Male Reproduction and Sexual Function

1996-97            Chair, Liaison Committee,  Society for Basic Urologic Research

1990-93 Executive Council, American Society of Andrology

1992-93            Nominating Committee, American Society of Andrology

1992-93            Andrology Laboratory Committee, American Society of Andrology

1991-93 Nominating Committee, RBPG, American Fertility Society

1993               Prize Presentation Committee, American Fertility Society

1987-90 Chair, Student Affairs Committee, American Society of Andrology

1988-90 Membership Committee, American Society of Andrology

 

 

 

PROFESSIONAL ACTIVITIES:

1.                  President, American Society of Andrology (2003-2004)

2.                  Treasurer, American Society of Andrology (1994-1998)

3.            Editorial Board, Endocrinology (1998-2002)

4.            Associate Editor, Journal of Andrology (1992-1997)

5.            Journal Reviewer (ad hoc): Molecular Endocrinology, Proceedings of the National Academy of Science, Nature,  Cancer Research,  Oncogene, Prostate, Biology of Reproduction, Journ­al of Endocri­nology, Endocrine, Neuroendocrinolog­y, American Journal of Physiology, Differentiation,  American Journal of Pathology, Environmental Health Perspectives, J Toxicology,  Fertility and Sterility, Journal of Reproduction & Fertili­ty, Urology, J Urology, Inter­nation­al Jour­nal of Andro­logy, Molecular Reproduction & Development, J Assisted Reproduction, Journal of Histochemistry and Cytochemistry,

6.         Grant Reviewer (ad hoc):

National Science Foundation, March of Dimes Foundation, Veterans Administration

7.         Study Sections:

NIH Site Reviewer, Oregon Regional Primate Research Center, 1988

            NIH Special Emphasis Panel: Regulation of Prostatic Growth, 06/93

NIH Biochemical Endocrinology Study Section, 10/95

NIH Reproductive Endocrinology Study Section, 10/96

NIH Special Emphasis Panels: Pediatric Urology Centers, 1996; Urology Centers, 03/99; Pathology B, 08/99; Urology,11/02; Reproductive Endocrinology, 10/01; 03/02; 03/03; 10/03

NIH Cooperative Specialized Infertility Research Centers, 05/02

NIH/NIDDK Program Project Site Reviewer, 12/99

NIH/NIEHS Program Project Site Reviewer, 03/01;  01/03 (Chair); 11/03 (Chair)

DOD Prostate Cancer Research Program, Molecular Biology Panel, 1998

8.                  Scientific Advisory Panels:

Department of Defense Prostate Cancer Research Program, Integration Panel (IP) Member, 2000-2005 (Executive Committee Member, 2002-2004)

NIH – National Institute of Environmental Health External Scientific Review Committee, 2004-2008

Center for Cancer Research and Therapeutic Development, External Advisory Committee, Clark-Atlanta University,

National Assessors Panel for Cancer Research, Victoria,  Australia, 2001

NTP/NIEHS Endocrine Disruptors Low-Dose Peer Review Panel, October, 2000

9.                  Scientific Session/Symposium Moderator:

AUA/SBUR Summer Research Conference Organizing Committee, 2005

Gordon Research Conference: Hormonal Carcinogenesis, 1997, 2001

Gordon Research Conference: Reproductive Tract Biology, 1998, 2004

Endocrine Society Annual Meeting, 1999, 2001

Society for Basic Urologic Research/Fourth World Congress in Urologic Research,2001

American Society of Reproductive Medicine­, 1990-1992, 1997, 2000

American Society of Andrology Meet­ing, 1989-1991, 1995, 1997, 2000, 2002-2004

Ameri­can Association for Can­cer Research, 1994

10.            Certification:

High Complexity Clinical Laboratory Director, American Association of Bioanalysts, (1994)

 

 

 

TEACHING:

Human Physiology & Pathophysiology 302: Male Reproduction Lectures

Graduate College Integrative Lecture Series 510:  Hormones & Cancer Lectures

 

LABORATORY TRAINEES:  

Postdoctoral Fellows:

William Chang, DVM, PhD, 1997-2000 (AFUD Scholar; NRSA Fellow)

Oliver Putz, PhD, 1998-2002

Yong Bing Pu, MD, PhD, 2001-present

Liwei Huang, MD, PhD, 2001-present (AFUD Scholar)

 

Visiting Scientists:

Shu-Hua Ye, MD, 1990-96, Research Associate, University of Illinois

Helga Habermann, MD, 1998-2000, Assistant Professor, University of Gratz, Austria

 

Graduate Students:       

Carl Woodham, PhD, 1998-2004 (NRSA recipient)

 

Medical Students:

Suresh Vedantham, MD, 1985-87, University of Chicago

Kenneth Gordon, MD, 1984-85, Columbia University

Christina Dothinger, 2003-2004

 

Research Residents:

Roger Lalich, DO, 1987-88, University of Wisconsin    

C. Sawetawan, MD, 1991-92, University of Texas

Brijesh Kapoor, MD, 1995

Michael Marmar, MD, 1996-97

Steven Kim, MD, 1997-98

Christopher Schwartz, MD, 1998-99

Vibha Sabharwal MD, 1999-00

Patrick Springhart, MD, 2000-01

Jason Gilleran, MD, 2001-2002, University of Texas Southwestern

Shumyle Alam, MD, 2002-2003, University of Kentucky

David Hepps, MD, 2004-2005

 

Dissertation Committee:

Jennifer McCafferty, PhD, 1999, Univ of Miami School of Medicine

Jason Derry, PhD, 2001, Department of Genetics, UIC

Dubravka Markovic, PhD, 2001, Dept of Microbiology & Immunology, UIC

Yan Wang, PhD, 2002, College of Pharmacy, UIC

Natasa D. Pajkovic, 2003-, College of Pharmacy, UIC

 

 

INVITED LECTURES (past 6 years):

“Signaling mechanisms regulating proliferation and programmed cell death during prostate development” Society for Basic Urologic Research annual Meeting, Savannah, Georgia, December 9-12, 2004.

 

“Hormonally mediated immune responses in the prostate gland”, International Inflammation Symposium, Monash University, Melbourne, Australia, November 28-30, 2004.

 

“The role of estrogens in prostate development and carcinogenesis”, Clark-Atlanta University, November 12, 2004.

 

“Influence of estrogen and retinoic acid receptors on regulation of prostate cancer growth” Prouts Neck Prostate Cancer Meeting, Prouts Neck Maine, November 4-7, 2004.

 

“Estrogen imprinting of the prostate gland via methylation”, Joint NIEHS/ACC Developmental Toxicology and Fetal Basis of Adult Disease Grantee Meeting, NIEHS, Research Triangle Park, NC, March 8-9, 2004.

 

“Prolactin regulation of prostate growth and inflammation”, Prolactin Gordon Research Conference, Ventura, CA, Feb 2-5, 2004.

 

“The Role of Estrogens in Prostate Development and Carcinogenesis”, Michigan State University, Lansing, MI, Oct 2-3, 2003.

 

“The Role of Estrogens in Prostate Development and Carcinogenesis”, Department of Medicine, Endocrinology Division, Mt Sinai Hospital, NYC, Sept 24-25, 2003.

 

“Estrogenic Exposures: Potential role in prostate development and carcinogenesis”, The Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, June 27, 2003.

 

“Estrogens and Prostate Development and Carcinogenesis”, The Endocrine Society Annual Meeting, Symposium on Steroid Receptors in Prostate Cancer, Philadelphia, June 19, 2003

 

“Estrogenic regulation of steroid receptors, morphogens and signaling pathways during prostate development”, Eppley Institute for Cancer Research, University of Nebraska Medical Center , Omaha, NE, May 1, 2003

 

“Estrogenic Regulation of Homeobox Genes and Signaling Pathways during Prostate Development”, Testis Workshop, Phoenix, AZ, March 26-29, 2003

 

“Differential Gene Expression in Estrogenized Rat Prostate”, Society for Basic Urologic Research Fall Symposium, Tucson, AZ, Dec 5-8, 2002

 

“Postnatal Estrogen Exposure and Prostate Development”, Gordon Research Conference on Reproductive Tract Biology, New London, CT, July1-5, 2002

 

“Reprogramming of prostatic steroid receptor expression by developmental estrogen exposure”, University of Massachusetts, May 13-14, 2002

 

“Estrogens and Prostate Cancer”, American Society of Andrology Postgraduate Course, Seattle, WA, April 27, 2002

 

“Might maternal estrogens predispose prostate disease?”, Department of Medicine, Columbia University, New York City, March 1, 2002

 

“Reprogramming of prostatic steroid receptor expression by developmental estrogen exposure”, National Institute of Environmental Health and Safety, January 11, 2002

 

“Estrogen in Prostate Development”  e.Hormone Conference on Endocrine Disruption, Tulane University, New Orleans, LA, Oct 18-20, 2001

 

“Estrogenic effects on retinoic acid signaling in the rat prostate gland”, Gordon Research Conference on Hormonal Carcinogenesis, Kimball Academy, NH, July 8-13, 2001.

 

“Steroid receptor pathways involved in estrogen imprinting of the prostate gland”, Department of Physiology, University of Wisconsin, Madison, WI, May 9, 2001.

 

“Steroid receptor pathways in estrogen programming of prostate development”, Keynote Lecture, Michigan Prostate Research Consortium, Detroit, MI, April 28, 2001.

 

“Neonatal estrogen programming of prostate growth”, Department of Biochemistry, University of Arizona, Tucson, AZ, Feb 15-17, 2001.

 

“Prenatal  DES:  Impaired  Prostate Development”,  National Institute of Environmental Health and Safety, Division of Extramural Research and Training Science Retreat, Molecular Basis of Environmental Disease, Pine Needles Resort, NC, Dec 4-5, 2000.

 

“Stromal-epithelial steroid receptors in normal and estrogenized rat prostate”, Society for Basic Urologic Research Fall Symposium, Sanibel Island, FL, November 9-12, 2000.

 

“Androgen and estrogen receptors in prostate development”, Hormones and Cancer 2000, Port Douglas, Australia, November 3-7, 2000.

 

“Influence of neonatal estrogens on mature prostate function”, Australian Academy of Science, Boyden Research Conference: Estrogens and Male Health; Sydney, Australia, November 2-3, 2000.

 

“Andrology laboratory issues in the era of ICSI, MESA and TESE”, American Society of Reproductive Medicine Workshop, San Diego, CA, October 24, 2000.

 

“Effects of prenatal and neonatal steroid exposure on prostate development” and “ERαKO and ERßKO transgenic mice as prostate models”, NIH Workshop on Prostate Growth and Aging, Bethesda, MD, September 13-15, 2000.

 

“Effects of estrogenic exposures on prostate development”, American Institute for Cancer Research, 10th Annual Research Conference, Washington DC, August 31-September 1, 2000.

 

“Prostate cancer: The predictive value of androgen receptor analysis”, Society of Toxicology, Midwest Regional Chapter Annual Meeting, Lincolnshire, IL, May 12, 2000.

 

“The new Estrogen Receptor β”, International Prostate Health Council, Antwerp, Brussels, February 25, 2000.

 

“Estrogen Imprinting of Prostate Gland Development and Function” Keynote Lecture, Triangle Consortium for Reproductive Biology, Research Triangle Park, North Carolina, February 12, 2000.

 

“Early imprinting of the rat prostate gland”, Gordon Research Conference on Hormonal Carcinogenesis, August 1-5, 1999, Tilton College, NH.

 

“Developmental estrogenization of the prostate gland”, American Urologic Association Research Conference, July 30-August 1, 1999, Houston, TX.

 

“Neonatal estrogen imprinting of the prostate gland”, Department of Biochemistry, Univer­sity of Miami, May 4, 1999.

 

“Molecular biology of androgen receptors”, Symposium on Androgen Replacement in Elderly People.  Mayo Clinic, Palm Springs, CA, March 18-20, 1999.

 

“Androgen receptor status as a prognostic indicator of response to hormone therapy for prostate cancer”,  Department of Urology, University of Maryland, March 9, 1999.

 

“Developmental estrogenization of the prostate gland”, Department of Biochemistry, University of Maryland, March 8, 1999.

 

“Developmental estrogenization of the prostate gland” Environmental Protection Agency, Raleigh, NC, Sept 16-17, 1998.

 

“Cell-cell mediated signals associated with estrogen-induced developmental defects in the prostate gland”, Gordon Research Conference on Environmental Endocrine Disruptors, Plymouth, NH, July 12-17, 1998.

 

“Estrogen imprinting of the rat prostate gland”, International Symposium on the Biology of Prostate Growth, Bethesda, MD, March 15-18, 1998.

 

"Hormone Action: Overview".  International Symposium on Biology of Prostate Growth, Washington DC, March 29, 1996.

 

"Androgen Receptor and Responsiveness: Hormonal and Developmental Regulation", Gordon Research Conference, Reproductive Tract Biology, New Hampshire, July 12, 1994.

 

"Development of the Prostate", NIH Symposia: Reproduction in the Aging Male, Bethesda, MD, November 26-27, 1990

PUBLICATIONS:

 

PEER-REVIEWED JOURNALS:

 

 1.        Prins GS and Zaneveld LJD: Distribution of spermatozoa in the rabbit vas deferens.  Biol Reprod 21:181-185, 1979.

 2.        Prins GS and Zaneveld LJD: Radiographic study of fluid transport in the vas deferens during sexual rest and following sexual activity.  J Reprod & Fertil 58:311-319, 1980.

 3.        Prins GS and Zaneveld LJD: Contractions of the rabbit vas deferens following sexual activity: a mechanism for proximal transport.  Biol Reprod 23:904-909, 1980.

 4.        Lee C, Prins GS, Henneberry M and Grayhack JT: Effect of estra­diol on the rat prostate in the presence and absence of testos­terone and pituitary.  J Androl 2:293-299, 1981.

 5.        Prins GS and Lee C: Influence of prolactin-producing pituitary grafts on the in vivo uptake, distribution and disappearance of (3H) testosterone and (3H) dihydrotestoste­rone by the rat prostate lobes.  Endocrinology 110:920-925, 1982.

 6.        Prins GS and Lee C: Comparison of the prostatic response to pituitary grafts in castrate rats treated with testosterone and dihydrotestosterone.  J Androl 3:305-312, 1982.

 7.        Prins GS and Lee C: Effect of protease inhibitors on androgen receptor analysis in rat prostate cytosol.  Steroids 40:189-201, 1982.

 8.        Prins GS and Lee C: Biphasic response of the rat lateral prostate to increasing levels of serum prolactin.  Biol Reprod 29:938-945, 1983.

 9.            Scommegna A, Rao R and Prins GS: University of Chicago In Vitro Fertilization Program at Michael Reese Hospital and Medical Center.  J IVF & Embryo Transfer, 1:90-93, 1984.

10.       Prins GS and Vogelzang RL: Inherent sources of ultrasound variability in relation to follicular measurements.  J IVF & Embryo Transfer, 1:221-225, 1984.

11.       Prins GS and Ross LS: Properties of human epididymal sper­matozoa obtained from an alloplastic spermatocele: motility assessment and penetration of zona-free hamster oocytes in the presence and absence of caffeine.  Fertil Steril, 44:401-405, 1985.

12.       Prins GS and Weidel L: A comparative study of buffer systems as cryoprotectants for human spermatozoa.  Fertil Steril 46:147-149, 1986.

13.       Ross LS and Prins GS: Alloplastic spermatoceles: a five year experience. J Urology 36:410-412, 1986.

14.            Weidel L and Prins GS: Cryosurvival of human spermatozoa frozen in eight different buffer systems.  J Andrology 8:41-47, 1987.

15.       Prins GS: Prolactin alteration of cytosol and nuclear androgen receptors in the ventral, dorsal, and lateral lobes of the rat prostate gland.  Endocrinology 120:1457-1464, 1987.

16.       Prins GS, Wagner C, Weidel L, Gianfortoni JG, Marut EL, Scom­megna A: Gonadotrop­ins augment maturation and fertilization of human immature oocytes cultured in vitro.  Fertil Steril 47:1035-1037, 1987.

17.            Scoccia B, Blumenthal P, Wagner C, Prins GS, Scommegna A, Marut EL: Compari­son of urinary human follicle-stimulating hormone and human menopausal gonado­tropins for ovarian stimulation in an in-vitro fertilization program.  Fertil Steril 48:446-449, 1987.

18.       Prins GS, Bartke A, Chandrasheker V, Reiher J, Hodges S, Meyers R: Effects of  bromocriptine and ectopic pituitary transplants on pituitary and hypothalamic nuclear androgen receptors in the male hamster.  Neuroendocrinology 47:236-240, 1988.

19.             Carson SA, Reiher J, Scommegna A, Prins GS: Antibody binding patterns in infertile males and females as detected by immuno­bead test, gel-agglutination test, and 20.

20.             Lalich RA, Marut El, Prins GS, Scommegna A: Life-table analysis of intrauterine insemination pregnancy rates.  Am J Obstetrics & Gynecology 158:908-984, 1988.

21.       Lalich RA, Vedantham S, McCormick N, Wagner C, Prins GS: Relation­ship between heparin binding site density and hamster ova penetrating capacity of human spermato­zoa.  J Reprod Fertil 86:297-302, 1989.

22.            Scoccia B, Prins GS, Scommegna A, Marut EL:  Comparison of urinary hFSH and HMG protocols for ovarian stimulation. GINE-DIPS. Revista Hispano-Americana de Obstetric­ia y Ginecologia 3:119, 1989.

23.       Prins GS: Differential regulation of androgen receptors in the separate rat prostate lobes: androgen independent expression in the lateral lobe.  J Steroid Biochem 33:319-326, 1989.

24.       Prins GS, Bartke A, Steger RW: Influence of photoinhibition, photostimulation and prolactin on pituitary and hypothalamic nuclear androgen receptors in the male hamster.  Neuroen­docrinology 52:511-516, 1990.

25.       Prins GS, Birch L, Greene GL: Androgen receptor localization in different cell types of the adult rat prostate.  Endocri­nology 129:3187-3199, 1991.

26.       Prins, GS: Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptor expres­sion. Endocrinology 130:2401-2412, 1992.

27.       Prins GS, Cooke P, Birch L, Donjacour AA, Yalcinkaya T, Siiteri PK, Cunha, GR: Androgen receptor expression and 5-α-reductase activity along the proximal-distal axis of the rat prostatic duct.  Endocrinology 130:3066-3073, 1992.

28.       Prins GS, Cecim M, Birch L, Wagner TE, Bartke A. Growth response and androgen receptor expression in seminal vesicles from aging transgenic mice with human and bovine growth hor­mone. Endocrinology 131:2016-2023, 1992.

29.       Parr MB, Ren HP, Russell L, Prins GS, Parr EL: The urethral glands of the male murine genital tract contain secretory component and IgA plasma cells and are targets of testoster­one. Biology of Reproduction 47:1031-1039, 1992.

30.       Prins GS, Birch L:  Immunocytochemical analysis of androgen receptor along the ducts of the separate rat prostate lobes following androgen withdrawal and replace­ment.  Endocrinology 132:169-178 1993.

31.       Prins GS, Woodham C, Lepinske M, Birch L:  Effects of neonatal estrogen on prostatic secretory genes and their correlation with androgen receptor expression in the adult rat prostate lobes.  Endocrinology 132:2387-2398, 1993.

32.            Sawetawan C, Bruns E, Prins GS:  Improvement of post-thaw motility in poor quality  human semen. Fertility & Sterility 60:706-710, 1993.

33.            Kramer RY, Garner DL, Bruns ES, Ericsson SA, Prins GS: Comparison of motility and flow cytometric assessments of seminal quality in fresh, 24-hour extended and

cryopreserved human spermatozoa.  J Andrology 14:374-384, 1993.

34.       Burton BK, Prins GS, Verp MS:  A prospective trial of prenatal screening for Down syndrome using maternal serum alpha-fetoprotein, hCG and unconjugated estriol.  Am J Obstetrics & Gynecology 169:526-530, 1993.

35.            Santolaya J, Jessup J, Kahn D, Prins GS, Burton BK: Patients with low mid-trimes­ter maternal serum unconjugated estriol have an increased risk of pregnancy loss. Am J Human Genetics 53:1454, 1993.

36.            Scommegna A, Ye S, Prins GS: Bromocryptine reverses the inhibitory effect of macrophag­es on sperm motility.  Fertility & Sterility 61:331-335, 1994.

37.            Vornberger W, Prins GS, Musto NA, C Suarez-Quian: Immunocytochemical localiza­tion of androgen receptor in rat testis: New implications for androgen regulation of spermatogenesi­s.  Endocrinology 134:2307-2316, 1994.

38.            Knudson G, Ross LS, Stuhldreher D, Houlihan D, Bruns E, Prins GS: Prevalence of sperm bound antibodies in infertile men with varicocele: The effect of varicocele ligation on antibody levels and semen response. J Urology 151:1260-1262, 1994.

39.            Pertschuk LP, Feldman JG, Brady KA, Levine M, RJ Macchia, DS Kim, D Etwaru, WL Thelmo, KB Eisenberg, E Rainford, Prins GS, Greene GL: Immunocytochemical assay for androgen receptors in prostate cancer: A pro­spective study of 63 cases with long-term follow-up.  Annals of Surgical Oncology 1:495-503, 1994.

40.      Ciofi P, Krause JE, Prins GS, Mazzuca M: Presence of nuclear androgen receptor-like immunoreactivity in neurokinin B-containing neurons of the hypothalamic arcuate nucleus of the adult male rat.  Neuroscience Lttrs 182:193-196, 1994.

41.       Lee C, Sutkowski DM, Sensibar JA, Zelner D, Kim I, Amsel I, Shaw N, Prins GS, Kozlowski JM: Regulation of proliferation and performance of differentiated functions in androgen sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone.  Endocri­nology 136:796-803, 1995.

42.       Prins GS, Birch L:  The developmental pattern of androgen receptor expression in the rat prostate lobes is altered following neonatal exposure to estrogen.  Endocrinol­ogy 136:1303-1314, 1995.

 43.            Rosenzweig BA, Bolina PS, Birch L, Moran C, Marcovici I, Prins GS:  Location and concentration of estrogen, progesterone and androgen receptors in the bladder and urethra of the rabbit.  Neurology & Urodynamics 14:87-96, 1995.

44.            Freeman LM, Padgett BA, Prins GS, Breedlove SM:  Distribution of androgen receptor immunoreactivity in the spinal cord of wild-type, androgen-insensitive and gonadectomiz­ed male rats.  J Neurobiology 27:51-59, 1995.

45.            Pertschuk LP, Schaeffer H, Feldman JG, Macchia RJ, Kim Y, Eisenberg K, Braithwai­te LV, Axiotis CA, Prins GS, Greene, GL: Immunostaining for prostate cancer androgen receptor, in paraffin, identifies a subset of men with poor progno­sis. Lab Invest 73:302-305, 1995

46.             Prins GS and C Woodham: Autologous regulation of androgen receptor mRNA in the separate lobes of the rat prostate gland. Biology of Reproduction 53:609-619, 1995.

47.             Iqbal J, Swanson JJ, Prins GS, Jacobson CD: Androgen receptor-like immunoreactivi­ty in the brazilian opossum brain and pituitary: Distribution and effects of castration and testosterone replacement in the adult male. Brain Research 703:1-18, 1995.

48.       Shirai T, Takahashi S, Mori T, Imaida K, Futakuchi M, Ye SH, Prins GS, Ito N: Immunohis­tochemical demonstration of androgen receptor in paraffin embedded rat prostate and its status in various conditions including preneoplastic and neoplastic lesions induced by 3,2'-dimethl-4-aminobiphenyl with or without testosterone.  Urol Oncol 1:263-268, 1995.

49.       Prins GS, Jung MH, Vellanoweth, Chatterjee B, Roy AK:  Age-dependent expres­sion of the androgen receptor gene in the prostate and its implication in cellular differentiation and hyperplasia.  Developmen­tal Genetics 18:99-106, 1996.

50.            Matsumoto A, Arai Y, Toyoda F, Kikuyama S,  Prins GS: Immunocytochemical analysis of androgen receptor in the abdominal glands of the cloaca of male red-bellied newts, Cynops pyrrhogaster.  Zoological Science 13:429-433, 1996.

51.            Hayward SW, Baskin LS, Haughney PC, Cunha AR, Foster BA, Dahiya R, Prins GS, Cunha GR: Epithelial development in the rat ventral prostate, anterior prostate and seminal vesicle.  Acta Anat 155:81-93, 1996.

52.             Hayward SW, Baskin LS, Haughney PC, Foster BA, Cunha AR, Dahiya R, Prins GS, Cunha GR: Stromal development in the ventral prostate, anterior prostate and seminal vesicle of the rat.  Acta Anat 155:94-103, 1996.

53.             Smith GT, Brenowitz EA, Prins GS: Use of PG-21 immunocytochemistry to detect androgen receptors in the songbird brain. J Histochem Cytoch 44:1075-1080, 1996.

54.             Matsumoto A, Arai Y, Prins GS:  Androgenic regulation of androgen receptor immunoreactivity in m­otorneurons of the spinal nucleus of the bulbocavernosus of male rats.  J N­­euroendocrinology 8:553-559, 1996.

55.            Santolaya J, Jessup J, Anderson R, Burd LI, Prins GS, Burton BK: Pregnancy outcome in patients with unexplained high or low midtrimester maternal serum unconjugated estriol.   J Reprod Med 41:87-89, 1996.

56.       Mora GR, Prins GS, Mahesh VB: Autoregulation of androgen receptor protein and mRNA in rat ventral prostate is protein synthesis dependent.  J Steroid Biochem 58:539-549, 1996.

57.       Jordan CL, Padgett B, Hershey J,  Prins GS, Arnold A:  Ontogeny of androgen receptor  i­mmunoreactivity in lumbar motorneurons and in the sexually dimorphic levator ani muscle of male rats.  J Comparative Neurology 379:88-98, 1997.

58.       Sonea I, Iqbal J, Prins GS, Jacobson CD: Ontogeny of androgen receptor-like immunoreactivity in the reproductive tract of male Monodelphis domestica (opos­sum).   Biol Reprod  56:852-860, 1997.

59.       Prins GS and L Birch: Neonatal estrogen exposure up-regulates estrogen receptor expression in the developing and adult rat prostate lobes. Endocrinology 138:1801-1809, 1997.

60.            Yokosuka M, Prins GS, Hayashi S: Co-localization of androgen receptor and nitric oxide synthase in the ventral premammillary nucleus of the newborn rat: An immunohistochemic­al study. Devel Brain Research 99:226-233, 1997

61.             Ilekis JV, Connor JP, Prins GS, Ferrer K, Niederberger C, Scoccia B: The level of growth factor receptor correlates with the level of the androgen receptor in ovarian cancer. Gynecologic Oncology 66:250-254, 1997.

62.             Prins GS, Sklarew RJ, Pertschuk LP:  Image analysis of androgen receptor immunostaining in prostate tumors accurately predicts response to hormonal therapy. J Urology 159:641-649, 1998.

63.       Prins GS, Marmer M, Woodham C, Chang W, Kuiper G, Gustafsson J-A, Birch L: Estrogen receptor beta mRNA ontogeny in the prostate of normal and neonatally estrogenized rats.  Endocrinology 139:874-883, 1998.

64.            Matsumoto A, Prins GS:  Age-dependent changes in androgen receptor immunoreactivi­ty in motorneurons of the spinal nucleus of the bulbocavernosus in male rats.  Neuroscience  Letters 243:29-32, 1998.

65.            Kasper S, Sheppard PC, Yan Y, Pettigrew N, Prins GS, Dodd JG, Duckworth ML, Matusik RJ:  Development and progression of prostate tumors in transgenic mice by probasin targeted SV40 large T-antigen: A model for prostate cancer. Laboratory Investigation 78:319-333, 1998.

66.       Yong EL, Tut TG, Ghadessy FJ, Prins GS, Ratnam SS:  Partial androgen insensitiv­ity and correlations with the predicted 3-D structure of the androgen receptor ligand-binding domain. Molecular & Cellular Endocrinology 137:41-50, 1998.

67.            Balthazart J, Foidart A, Houbart M, Prins GS, Ball GF:  Distribution of androgen receptor-immunoreactive cells in quail forebrain and their relationship with aromata­se immunoreactivit­y. J Neurobiology 35:323-340, 1998.

68.            Roman BL, Timms BG, Prins GS, Peterson RE: In utero and lactational exposure of the male rat to 2,3,7,8-Tetrachlorodibenzo-p-dioxin impairs prostate development: 2. Effects on growth and cytodifferentiation.  Toxicology and Applied Pharmacology 150(2): 254‑270, 1998.

69.       Chang WY, Wilson MJ, Birch L, Prins GS:  Neonatal estrogen stimulates prolifera­tion of periductal fibroblasts and alters the extracellular matrix composition in the rat prostate.  Endocrinology 140:405-415, 1999.

70.       Boyd SK, Wissing KD, Heinsz JE, Prins GS: Androgen receptors and sexual dimorphisms in the larynx of the bullfrog.  General & Comparative Endocrinology 113:59-68, 1999.

71.       Prins GS, Dolgina R, Studney P, Kaplan B, Ross L, Niederberger C: Quality of cryopreserv­ed testicular sperm in patients with obstructive and ­­nonobstructive azoospermi­a.  J Urology 160 : 1504-1508, 1999.

72.       Chang WY, Birch L, Woodham C, Gold L, Prins GS:  Neonatal estrogen exposure alters the TGFb signaling system in the developing rat prostate and interrupts TGFß-mediated differentiation of the epithelium. Endocrinology 140:2801‑2813, 1999.

73.       Chang WY, Prins GS:  Estrogen Receptor-beta: Implications for the prostate gland.  Prostate  40:115-124, 1999. 

74.            Emerson SB, Greig A, Prins GS:  Androgen receptors in two androgen-mediated sexually dimorphic characters of frogs. General & Comparative Endocrinology 114(2):173‑180, 1999.

75.       Prins GS: Molecular biology of the androgen receptor. Mayo Clinic Proceedings:

            Testosterone Replacement in Elderly Men. 75:S32-35, 2000.

76.             Habermann H, Seo R, Cieslak J, Niederberger C, Prins GS, Ross L: In vitro fertilization outcomes after intracytoplasmic sperm injection with fresh or frozen-thawed testicular spermatozoa.  Fertility & Sterility 73:955-960, 2000.

77.       Jarred RA, Cancilla B, Prins GS, Cunha GR, Risbridger GP: Evidence that estrogens directly alter androgen regulated prostate development.  Endocrinology 141:3471-3477, 2000.

78.       Van Pett K, Bittencourt JC, Chan RKW, Li H-Y, Arias C, Prins GS, Perrin M, Vale W, Sawchen­ko P:  Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse.  J Comparative Neurology  428:191-212, 2000.

79.             Griffiths K, Denis LJ, Behre HE, Kreig M, Kyprianou N, Lee C, Mahler C, Petritisch P, Prezioso D, Prins GS, Tunn U, Vermeulen A:  Oestrogens and Prostatic Disease: An IPHC Study Group.  Prostate 45:87-100, 2000.

80.       Moga MM, Geib B, Zhou D, Prins GS:  Androgen receptor immunoreactivity in the forebrain of the Eastern Fence lizard (Sceloporus undulatus).  Brain Research 879: 174-182, 2000.

81.             Habermann H, Chang WY, Birch L, Mehta P, Prins GS:  Developmental exposure to estrogens alters epithelial cell adhesion and gap junction proteins in the adult rat prostate. Endocrinology 142:359-369, 2001.

82.             Ahlbom E, Prins GS, Ceccatelli S: Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism.  Brain Research 892:255-262, 2001.

 

83.             Prins GS, Birch L, Couse JF, Choi I, Katzenellenbogen B, Korach KS:  Estrogen imprinting of the developing prostate gland is mediated through stromal ERα:  Studies with  αERKO and  ßERKO mice. Cancer Research  61:6089-6097, 2001.

84.       Prins GS, Birch L, Habermann H, Chang WY, Tebeau C, Putz O, Bieberich C:  Influence of neonatal estrogens on rat prostate development.  Reprod Fertil Dev 13:241-252. 2001.

85.             Wang Y, Chang WY, Prins GS, van Breeman RB:  Simultaneous determination of all-trans, 9-cis, 13-cis retinoic acid and retinol in rat prostate using liquid chromatog­raphy - mass spectrometry.  J Mass Spectroscopy 36:882-888, 2001.

86.             Putz O, Kim S, Schwartz C, Cooper R, LeBlanc G, Prins GS: Neonatal low- and high-dose exposure to estradiol benzoate in the male rat: I. Effects on the prostate gland.  Biology of Reproduction 65:1496-1505,2001.

87.             Putz O, Schwartz C, Kim S, LeBlanc G, Cooper R, Prins GS: Neonatal low- and high-dose exposure to estradiol benzoate in the male rat: II. Effects on male puberty and the reproductive tract­. Biology of Reproduction 65:1506-1517, 2001.

88.             Bekir B, Koeneman K, Edland M, Prins GS, Zhau HE, Chung LWK: Androgen receptor mediates reduced tumor growth, enhanced androgen responsiveness and selected target gene transactivation in a human prostate cancer cell line.  Cancer Research 61:7310-7317, 2001.

89.             Habermann H, Ray V, Habermann W, Prins GS:  Alterations in gap junction protein expression in human BPH and prostate cancer.  J Urology 166, 2267-2273, 2001.

90.             Matsumoto A and Prins GS: Androgenic regulation of expression of androgen receptor protein in the perineal motorneurons of aged male rats. J Comp Neurol 443:383-387, 2002.

91.             Melnick R, Lucier G, Wolfe M, Hall R, Stancel G, Prins GS, Gallo M, Reuhl K, Ho SM, Brown T, Moore J, Leakey J, Haseman J, Kohn M:  Summary of the National Toxicology Programs Report of the Endocrine Disruptors Low-Dose Peer Review.  Environmental Health Perspectives 110: 427-431, 2002.

92.             Prins GS, Chang WY, Wang Y, van Breeman RB: Retinoic acid receptors and retinoi­ds are up-regulated in the developing and adult rat ventral prostate by neonatal estrogen exposure.  Endocrinology 143:3628-3640, 2002.

93.             Zhou Q, Nie R, Prins GS, Saunders PTK, Katzenellenbogen B, Hess RA:  Localiza­tion of androgen and estrogen receptors in the adult male mouse reproductive tract. J Andrology 23:870-881, 2002.

94.             Gilleran JP, Putz O, DeJong M, DeJong S, Birch L, Pu Y, Huang L, Prins GS:  The role of prolactin in the prostatic inflammatory response to neonatal estrogen.  Endocrinology 144:2046-2054, 2003.

95.             Derry JJ, Prins GS, Ray, V, Tyner AL: Altered localization and activity of the­ intracellul­ar ­tyrosine kinase BRK/Sik in prostate tumor cells. Oncogene 22:4212-4220, 2003.

96.             Woodham C, Birch L, Prins GS:  Neonatal estrogens down regulate prostatic androgen receptor levels through a proteosome-mediated protein degradation pathway.  Endocrinology 144: 4841‑4850, 2003.

97.             Oliveira CA, Nie R, Carnes K, Franca LR, Prins GS, Saunders P, Hess RA:  The antiestrogen ICI 182,780 decreases the expression of estrogen receptor-a but has no effect on estrogen receptor-b and androgen receptor in rat efferent ductules.  Reproductive Biology & Endocrinology 1:75-86, 2003.

 

 

98.             Huang L, Pu Y, Alam S, Birch L, Prins GS:  Estrogenic regulation of signaling pathways and homeobox genes during rat prostate development. J Andrology 25: 330-337, 2004.

99.             Goyal H, Braden TD, Williams, CS, Dalvi P, Mansour M, Williams JW, Bartol F, Birch L, Prins GS:  Abnormal morphology of the penis in rats exposed neonatally to estrogen is associated with altered profile of estrogen receptor a protein but not androgen receptor protein: A developmental and immunocytochemical study. Biology of Reproduction 70:284-297, 2004.

100.         Prins GS and Bremner W:  Andrology in the Twentieth Century: A commentary on our progress during the past 25 years.  J Andrology 25:435-440, 2004.

101.         Oliveira CA, Mahecha GAB, Carnes K, Prins GS, Saunders PTK, Hess RA: Differential hormonal regulation of estrogen receptors ERa and ERb and androgen receptor expression in the rat efferent ductules.  Reproduction 128:73-86, 2004.

102.         Pu Y, Huang L, Prins GS: Sonic Hedgehog-Patched-Gli signaling in the developing rat prostate gland: Lobe-specific suppression by neonatal estrogens reduces ductal growth and branching. Developmental Biology 273:257-275, 2004.

103.    Huang L, Pu Y, Alam S, Birch L, Prins GS: The role of Fgf10 signaling in gene expression and branching morphogenesis of the rat prostate gland: Lobe-specific suppression by neonatal estrogens.  Developmental Biology (in press).

104.         Nanda NK, Birch L, Greenberg N, Prins GS: MHC Class I and Class II ­are ex­pressed in both human and mouse prostate tumor microenvironment. Prostate (submitted).

105.            Bianco JJ, Hong W, Prins GS, Risbridger GP:   Evaluating the direct and indirect effects of neonatal estrogen imprinting on pathogenesis of the mature murine prostate gland. Endocrinology (submitted).

 

BOOK CHAPTERS:

 

 1.            Zaneveld LJD, Beyler SA, Prins GS, Taft F, Goodpasture J and Reddy J: Reversible vas deferens occlusion - a new device.  In: Reversal of Sterilization. Eds: Sci­arra J, Zatuchni G, Harper & Row, New York, pp. 81-90, 1978.

 2.        Prins GS, Zaneveld LJD and Schumacher GFB: Functional biochem­is­try of cervical mucus.  In: Human Ovulation. Ed: ESE Hafez, North Holland Publishing Co., New York, pp. 313-325, 1979.

 3.        Bartke A, Steger RW, Chandrashekar V, Prins GS: Role of prolactin in the neuroendo­crine control of male reproductive functions. In: Advances in Physiologi­cal Sciences. Eds: SK Manchanda, W Selvamurthy, VM Kumar, Manmillan India Ltd, pgs 494-501, 1992.

 4.        Prins GS:  Development of the prostate. In: Reproduc­tive Is­sues and the Aging Male. Eds: F Haselt­ine, A Paulsen, C Wang, Embry­onics, Inc, New York, p 101-112, 1993.

 5.        Prins GS: Semen Analysis. In: Embryology and Andrology Review Course. Ameri­can Association of Bioanalysts, 1994.

6.         Small E and Prins GS: Physiology and endocrinology of the prostate. In: Compre­hensive Textbook of Genitourinary Oncology. Ed: NJ Vogelzang, P Scardino, WU Shipley, DS Coffey, Williams & Wilkins, Baltimore, Chpt 37, pg 600-620, 1995.

7.            Suarez-Quian CA, Oke W, Vornberger W, GS Prins, XiaoS, Musto N: Androgen receptor distribution in the testis.  In: Cellular and Molecular Regulation of Testicular Cells. Ed: C Desjardins, Springer-Verlag Inc, New York, Chpt 13, pg 189-212, 1996.

8.         Prins GS: Developmental estrogenization of the prostate gland.  In: Prostate: Basic and Clinical Aspects. Ed: Rajesh K. Naz, CRC Press Inc., Boca Raton, Florida, Chpt 10, pg 247-263, 1997.

9.         Prins GS: Semen.  In: Encyclopedia of Reproduction. Ed: E. Knobil and JD Neill, Academic Press, pg 360-367, 1998.

10.       Small E, Taplin ME, Prins GS:  The androgen receptor and the physiology and endocrinology of the prostate gland.  In: Compre­hensive Textbook of Genitourinary Oncology, Second edition. Ed: NJ Vogelzang, P Scardino, WU Shipley, DS Coffey, Williams & Wilkins, Baltimore, 2000.

11.             Habermann H, Habermann W, Ray V, Prins GS:  Gap Junctions in Prostate Dis­ease.  In:  Andrology in the 21st Century. Ed: B. Robaire, Chemes H, Morales CR, Medimound Publications, pg 595-600, 2001

12.       Putz O and Prins GS: Prostate gland development and estrogenic imprinting.  In:  Steroid Hormones and Cell Cycle Regulation.  Ed: K Burnstein, Kluwer Academic Publishers, Norwell, MA, pg 73-89, 2002.


ABSTRACT PRESENTATIONS:

 

1.            Zaneveld LJD, Prins GS and Schumacher GFB: Biochemical para­meters of cervical mucus.  VIII Mott Center Symposium on Human Ovula­tion, Detroit, MI, 1977.

2.         Prins GS and Zaneveld LJD: Radiographic study of fluid transport in the vas deferens. American Physiology Society,   The Physiologist 21(4):94, 1978.

3.         Prins GS and Zaneveld LJD: Sperm transport through the vas deferens.  Proceed­ings of the 4th Annual American Society of Andrology, Houston, TX, pp. 23, 1979.

4.         Prins GS and Zaneveld LJD: Mechanism of proximal fluid transport in the vas deferens. Society for the Study of Reproduction Annual Meeting,  Biol Reprod 20:63A, 1979.

5.         Lee C, Henneberry M and Prins GS: Effect of estradiol on the rat prostate. Society for the Study of Reproduction Annual Meeting, Biol Reprod 22(1):91A, 1980.

6.         Prins GS and Lee C: Effect of prolactin on the retention of dihydrotestosterone in the rat prostate. American Society of Andrology Annual Meeting, J Androl 2:22, 1981.

7.         Prins GS and Lee C: The prolactin effect on dihydrotestosterone-mediated growth of the rat prostate. Society for the Study of Reproduction Annual Meeting, Biol Reprod 24(1):29­A, 1981.

8.         Prins GS and Lee C: Effect of proteolytic enzyme inhibitors on androgen receptors in the rat prostate. International Steroid Congress, Jerusalem, Israel, Sept 3, J Steroid Bioch­em 17:38, 1982.

9.         Prins GS and Lee C: Biphasic response of rat prostate to increas­ing prolactin. , American Society of Andrology Annual Meeting,  J Androl 4:55, 1983.

10.       Prins GS and Vogelzang RL: Inherent sources of ultrasound variability affect accurate monitoring of follicular number and development.  First International Congress on In Vitro Fertilization,  J IVF & Embryo Transfer 1:132, 1984.

11.       Prins GS and Ross LS: Human spermatozoa from an artificial spermatocele: motility and penetration of zona-free hamster oocy­tes in the presence and absence of caffeine.  Internatio­nal Society of Andrology, J Andrology Suppl 6:103, 1985.

12.       Ross LS and Prins GS: Alloplastic spermatoceles: five years experience. Internatio­nal Society of Andrology, J Androlo­gy Suppl 6:102, 1985.

13.            Weidel L and Prins GS: A comparative study of buffer systems as cryoprotectants for human spermatozoa. Internatio­nal Society of Andrology, J Andrology 6:128, 1985.

14.       Prins GS, Gordon K and Andresen P: The effect of prolactin on human sperm motility and penetration of zona-free hamster ova.  Internatio­nal Society of Androlo­gy, J Andrology Suppl 6:35, 1985.

15.            Verlinsky Y, Pergament E, Prins GS, Marut EL: Preimplantation genetic diagnosis.  IVF World Congress on In Vitro Fertiliza­tion, Melbourne, Australia, November, 1985, pp. 227.

16.       Pratt DE, Prins GS, Andresen P, Weidel L, Marut EL: Charac­teri­zation of aspirated oocytes in HMG (Pergonal) and FSH (Metrodin) stimulated cycles in the primate.  Society for Gynecologic Investigation, Toronto, Canada, March 19-22, 1986, pp. 99.

17.       Prins GS: Prolactin effect on cytosol and nuclear androgen receptors in ventral, dorsal, and lateral rat prostate.  The Endocrine Society, Anaheim, CA, June 25-27, 1986, Abstract #712.

18.       Prins GS, Weidel L, Shangold G, Carson SA, Gianfortoni JG, Scommegna A, Marut EL: HMG in vitro enhances the maturation and fertilization of immature oocytes.  American Fertility Society, Toronto, Canada, September 27 - October 2, 1986, Abstract #205.

19.       Prins GS, Carson SA, Weddington L, Reiher J: Correlation of sperm-immunobead binding to agglutination and immobilization assays for antisperm antibodies.  American Fertility Society, Toronto, Canada, September 27, 1986, Abstract #139.

20.            Scoccia B, Zbella E, Carson SA, Gianfortoni JG, Scommegna A, Prins GS, Weidel L, Barnes R, Shangold G, Schreiber J, Marut EL: A comparison of hFSH (Metrodin) and hMG (Pergonal) for ovarian stimulation in an IVF-ET program.  American Fertility Society, Toronto, Canada, September 17, 1986.

21.       Prins GS, Reiher J: Androgens differentially regulate nuclear androgen receptor levels in the ventral, dorsal, and lateral rat prostate.  The Endocrine Society, Indianapolis, IN, June 9-12, 1987.

22.       Craig HR, Scoccia B, Benveniste R, Prins GS, Wagner C, Scommegna A, Marut EL: Detection of immunoreactive alpha-atrial natriur­etic peptide in human follicular fluid.  American Fertility Society, Reno, NV, September 27 - October 2, 1987.

23.       Prins GS: Current level of success for freezing human sperm.  NIH Workshop on Sperm Cryopreservation, Bethesda, MD, January 18-19, 1988.

24.       August A, Larsen A, Prins GS, Schreiber J: Apolipoprotein E synthesis by cultured human ovarian granulosa cells.  Society for Gynecologic Investigation, 35th Annual Meeting, Baltimore, MD, Abstract #19, pp. 69, 1988.

25.            Matusik RJ, Dodd JG, Prins GS: Prolactin-producing pituitary grafts induce prostatic binding protein gene in the rat lateral prostate.  The Endocrine Society, New Orleans, LA, 1988.

26.            Wagner CM, Graves CN, Wolf G, Prins GS: Developmental capacity following cold storage (4o C) of pronuclear and cleaving stage embryos is enhanced by sucrose.  American Fertility Society, Atlanta, GA, September 1988.

27.       Prins GS, Vedantham S, Wagner C, Lalich RA: Relationship between heparin binding characteristics and hamster ova penetrating capacity of human spermato­zoa.  J Andrology, 1989. American Society of Andrology, New Orleans, LA, 1989.

28.       Prins GS:  Autologous regulation of androgen receptor mRNA in the ventral, dorsal and lateral rat prostate lobes.  The Endocrine Society, Atlanta, GA, 1990.

29.       Bartke A, Steger RW, Chandrashekar V, Prins GS: Role of prolactin in the neuro­endocrine control of male reproductive functions. Sympo­sium on Basic and Clinical Aspects of Repro­duction, IInd Congress of Asian & Oceanian Physiologic Societies, New Delhi, India, November 12-15, 1990.

30.       Prins GS, Birch L, Ghosh PK, Bartke A: Androgen receptor content in seminal vesicles from young and aged transgenic mice with human or bovine growth hormone.  J Andrology, 1991. American Society of Andrology, Montreal, April 27, 1991.

31.            Scommegna A, Ye S, Prins GS: Suppression of prolactin in mice reverses the inhibitory effect of macrophages on human sperm motility.  Society of Gynecologic Investigation, San Antonio, TX, March 20-23, 1991.

32.       Prins GS, Birch L, Cohen H: Effect of neonatal estrogen on androgen receptor concentration and distribution in the rat prostate lobes.  The Endocrine Society, Washington DC, June 19-22, 1991.

33.       Garner DL, Kramer RY, Prins GS, Bruns ES, Ericsson SA: Interre­lationships between flow cytometry and sperm motility parameters in human semen.  Society for the Study of Reproduc­tion, Vancouver, British Columbia, July 28-31, 1991.

34.            Knudson G, Stuhldreher D, Houlihan D, Bruns E, Prins GS, Ross L: Relation of antisperm antibody to varicocele related infertility.  Northwest Conference, American Urologic Society, Scottsdale, AZ, November, 1991.

35.            Kramer RY, Prins GS, Bruns ES, Ericsson SA, Garner DL: Functional differences among fresh, 24-hour extended and cryopreserved human spermatozoa.  American Society of Androlo­gy, Washington DC, March 20-23, 1992.

36.       Prins GS, Woodham C, Birch L, Lepinske M: Effects of neonatal estrogen on prostatic secretory products and their correlation with androgen receptor expression in the adult rat prostate lobes.  The Endocrine Society, San Antonio, June 24-27, 1992.

37.       Birch L, Prins GS: Immunocytochemical analysis of androgen receptor along the ducts of the separate rat prostate lobes following castration-induced androgen withdrawal.  The Endocrine Society, San Antonio, TX, June 24-27, 1992.

38.       Parr MB, Ren HP, Russell L, Prins GS, Parr EL: The urethral glands of the male murine genital tract are targets of testoster­one and contain secretory component and IgA plasma cells.  American Soc for Immunol­ogy of Reproduction, Charleston, SC, June 10-13, 1992.

39.            Sawetawan C, Bruns E, Prins GS: Improvement of post-thaw motility in poor quality human semen. American Fertility Society, New Orleans, LA, November 3, 1992.

40.            Rosenzweig BA, Prins GS, Bolina PS, Birch L, Moran C, Marcovici I: Steroid receptors of the lower urinary tract in the rabbit.  The American College of Obstetrics & Gynecology, 1993.

41.            Pertschuk LP, Macchia RJ, Feldman DPH, Eisenberg BA, Prins GS, Greene GL: Immunocytochemical assay for androgen receptors in prostate cancer.  46th Annual Cancer Symposium of Society of Surgical Oncology, Los Angeles, CA  March 18-21, 1993.

42.       Prins GS, Woodham C: Androgen receptor gene transcription rates are differentially affected by androgens in the separate rat prostate lobes.  The Endocrine Society, Las Vegas, NV, p 509, June 11, 1993.

43.            Santolaya-Forgas J, Jessup J, Kahn D, Prins GS, Burton B: Patients with low mid-trimester maternal serum unconjugated estriol (MSuE3) have an increased risk of pregnancy loss.  American Society of Human Genetics, 1993.

44.       JH Ngan, GS Prins, L Birch, C Lee, R Sharifi: Effect of long term steroid deprivation on response of androgen receptor protein to dihydrotestosterone (DHT) in LNCaP cells.  Society for Basic Urologic Research, Houston, TX, December 2-5, 1993.

45.            Sutkowski DM, Amsel I, Sensibar JA, Prins GS, Koslowski JM, Lee C: Regulation of proliferation and secretory activity in androgen sensitive prostatic cancer cells, LNCaP, by androgen. SBUR, Houston, TX, Dec 2-5, 1993.

46.       J Kalamaras, GS Prins: Variability in sperm count and motility estimates using different counting chambers and CASA systems. American Society of Andrology, Springfield, IL, March 4-7, 1994, J Andrology 15 (Suppl):P-49.

47.       E Bruns, P Studney, A Eddie-Quartey, GS Prins: Comparison of SpermMar and ImmunoScreen antisperm antibody tests with the immunobead test. American Society of Andrology, Springfield, IL, March 4-7, 1994, J Andrology 15 (Suppl):P-52.

48.            Suarez-Quian CA, Vornberger W, Prins GS, Musto NA: Androgen receptor distribution in the rat testis: new implications for androgen regulation of spermatogen­esis. American Society of Andrology, Springfield, IL, March 4-7, 1994 J Andrology 15 (Suppl): P-35.

49.       JH Ngan, C Lee, J Sensibar, GS Prins, L Birch, R Sharifi: Androgen induced immediate androgen receptor, prostatic specific antigen (PSA) and cellular protein changes in long term androgen deprived human prostate cancer.  American Urologic Association, 1994.

50.       Prins GS, Birch L:  Neonatal estrogen up-regulates estrogen receptor in prostatic smooth muscle cells and increases extracellular TGFß1.  The Endocrine Society, Anaheim, CA, June 15-18, 1994, #1183.

51.            Arjmandi BH, Amin D, Prins GS, Woodham C, Alekel L: The role of androgens in intestinal calcium transport.  J Bone & Mineral Research, 9(suppl 1): S396, 1994.

52.      Iqbal J, Prins GS, Jacobson CD: Ontogeny of cells containing androgen receptor-like immunoreactivity in the brazilian opossum.  Soc for Neuroscience, Miami, Nov 13-18, 1994.

53.            Gustavson S, Zakon H, Prins GS: Androgen receptors in the brain, electroreceptors and electric organ of a wave-type electric fish. Soc for Neuroscience, Miami, Nov 13-18, 1994.

54.            Pertschuk LP, Feldman JG, Macchia RJ, Kim, YD, Axiotis CA, Prins GS, Greene, GL: Androgen receptor immunocytochemistry in paraffin sections predicts prostate cancer survival and endocrine response. American Association for Cancer Re­search: Basic and Clincal Aspects of Prostate Cancer, Palm Springs, Dec 8-12, 1994.

55.       Prins GS, Birch L, Woodham, C: Effect of neonatal estrogen on androgen receptor protein and mRNA levels in developing rat ventral prostate.  The Endocrine Society, Washington DC, June, 1995.

56.       Mora G, Prins GS, Mahesh VB: Testosterone regulation of androgen receptor expression in rat ventral prostate is protein synthesis mediated.  The Endocrine Society, Washington DC, June, 1995.

57.            Pertschuk LP, Schaeffer H, Feldman JG, Macchia RJ, Kim YD, Axiotis CA, Eisenbe­rg KB, Prins GS, Greene GL: Androgen receptor immunocytochemistry in prostate-cancer selects a subgroup of men with poor survival. Lab Invest 72:A 81, 1995.

58.            Foidart A, Houbart M, Prins GS, Balthazart. Distribution and neurochemical charac­terization of androgen receptor-containing cells in the quail brain.  Society of Neuroscien­ces, 1995.

59.      Iqbal J, Prins GS, Sonea I, Jacobson CD:  Effects of exogenous testosterone on androgen receptor-like immunoreactivity in the developing brazilian opossum brain.  Society of Neurosciences, 1995.

60.            Scoccia B, Ilekis JV, Connor JP, Prins GS, Viswaswaran A, Shi J, Jun N, Khan K: Epidermal growth factor expression directly correlates with androgen receptor levels in epithelial ovarian cancer.  American Society of Reproductive Medicine, Seattle, WA, October 7-12, 1995.

61.       Spear K, Ross LS, Niederberger CS, Prins GS, Brown B.: Postmortem sperm recovery and preservation: Technic and issues for posthumous reproduction.  North Central Section, American Urologic Society  Annual Meeting, Minneapolis, Sept 12-16, 1995.

62.            Schlegel PN, Niederberger CS, Spear K, Matthewa GJ, Yuan J, Lash C, Prins GS, Studney P, Dolgina R, Lamb DJ, Lipshultz LI, Ross LS: Sperm retrieved postmort­em: Its potential use for ICSI. American Urologic Association, 1996.

63.       Prins GS, Birch L, Ye SH, Ray V: Estrogen exposure leads to prostate lobe-specific dysplasia and adenomas in the aging rat. American Society of Andrology, Minneapo­lis, April 25-29, 1996.

64.            Dolgina R, Studney P, Ross L, Prins GS, Niederberger C: Double fluorescent stain for accurate assessment of human-hamster ICSI outcome. American Society of Andrology, Minneapolis, MN, April 25-29, 1996.

65.       Prins GS: Is there a place for sperm function testing in the era of managed care and ICSI?  Assisted Reproduction: State of the ART, Chicago, IL, May 2-4, 1996.

66.       Amin D, Prins GS, Armjandi B: Immunocytochemical evidence for androgen receptors in various intestinal segments of male rats. American Soc of Bone & Mineral Research,  J Bone Min 11(S1):T538, August 1996.

67.      Yuan J, Ross, LS, Niderberger CS, Prins GS, Dolgina R, Studney BS: Testicular sperm extraction is an effective adjunct to vasal and epididymal reconstruction for obstructive azoospermia. North Central Section Meetings, American Urologic Association, Oct, 1996.

68.            Dolgina R, Wolf G, Studney P, Kaplan B, Niederberger C, Ross L, Prins GS: Cryopreservation of sperm collected by TESE provides adequate post-thaw viability and successful IVF-ICSI pregnancies.  American Society of Andrology, Baltimore, Feb 25, 1997.

69.       Ross LS, Yuan J, Dolgina R, Wolf G, Studney P, Kaplan B, Niederberger C, Prins GS:  Routine testicular sperm extraction (TESE) during microsurgical vasal and epididymal reconstruction is safe and effective. American Urologic Association, April 14, 1997.

70.       Prins, GS, Birch L, Woodham C, Marmar M, Kuiper G, Gustafsson JA:  Estrogen receptor ß mRNA ontogeny in the rat prostate lobes and effects of neonatal estro­gen exposure on its expression pattern.  The Endocrine Society, Minneapolis, MN, June, 1997.

71.            Dolgina R. and Prins GS:  Motility of cryopreserved semen specimens declines over storage time in subpopulations of cryobankers.  American Society of Andrology Annual Meeting, Long Beach, CA, March 1998.

72.       Seo R, Niederberger C, Ross L, Prins GS, Dolgina R, Kaplan B.  Comparison of fertilization and pregnancy rates using fresh versus frozen testicular sperm for intracytoplasmic sperm injection.  American Urological Association, San Diego, CA, June 1-4, 1998, (J Urol 159:888).

73.       Chang WY, Birch L, Prins GS:  Neonatal estrogenization stimulates proliferation of a zone of periductal fibroblasts that impede ductal branching and cell-cell interactions in the developing rat ventral prostate.  International Symposium on the Biology of Prostate Growth, Bethesda, MD, March 15-18, 1998. Prostate 38:317, 1999.

74.       Prins GS:  Estrogen Imprinting of the rat prostate gland. International Symposium on the  Biology of Prostate Growth, Bethesda, MD, March 15-18, 1998, Prostate 38: 317, 1999.

75.      Onel E, Ross LS, Prins GS, Niederberger C, Dolgina R, Kaplan B.  Sperm retrieval and success of in vitro fertilization - intracytoplasmic sperm injection in men with nonobstructive azoospermia.  North Central Section (AUA), October, 1998.

76.       Seo RM, Onel E, Niederberger CS, Ross LS, Prins GS, Dolgina R, Zalensky A: Observation of telomere lengths in abnormal and normal human sperm. American Soc Reprod Med 70(1):P817, San Francisco, Oct 1-5, 1998.

77.       Chang WY, Birch L, Woodham C, Prins GS. Neonatal estrogen exposure alters the TGF-b signaling system in the developing rat prostate. Society for Basic Urologic Research, Portland, ME, Nov 12-15, 1998.

78.            Dolgina R and Prins GS. Functional assessment of cryopreserved human sperm obtained using overnight transport kit.  American Society of Andrology, Louisville, KY, April, 1999.

79.            Epstein JI, Partin AW, Kyprianou N, Hess DL, Prins GS, Marks LS: Prostate tissue effects of saw palmetto extract in men with symptomatic BPH.  American Urological Association, Dallas, TX, May 2-6, 1999.

80.      Putz O, Schwartz C, Kim S,  Birch L, Prins GS. Prostatic growth response to neonatal exposure of nonylphenol.  Keystone Symposium on Environmental Estrogens, Tahoe City, CA, Feb 1-5, 1999.     

81.       Chang WY, Birch L, Prins GS:  Neonatal estrogen elevates retinoic acid receptor (RAR) levels in the developing and adult rat ventral prostates.  The Endocrine Society, San Diego, CA, #P1-222, June 12-15, 1999.

82.            Dolgina R, Prins GS, Ross LS, Niederberger C: Successful use of cryopreserved sperm obtained by electroejaculation for in vitro fertilization/intracytoplasmic sperm injection. American Society for Reproductive Medicine, Toronto, Oct 25-30, 1999.

83.            Ahlbom E, Hampton M, Prins GS and  Ceccatelli S: In vitro treatment with t­estoster­one protects cerebellar granule cells against oxidative stress via a receptor-medi­ated mechanism.  Society of  Neurosciences, 1999.

84.             Hews Dk, Moga MM, Prins GS: Distribution of androgen receptor immunoreactivity in the brain of the Eastern fence lizard, Sceloporus undulatus. American Zoologist 39 (5): 28A, 1999.

85.            Habermann H, Chang WY, Birch L, Prins GS: Connexin 43 and 32 ontogeny in the rat prostate.  European Congress of Andrology, L’Aquila, Italy, March 24-27, 2000.

86.            Habermann H, Mehta P,  Prins GS: Connexin 43 and Connexin 32 ontogeny in the rat prostate and effect of neonatal estrogen exposure. American Society of Androlog­y, Boston, April 7-11, 2000.

87.            Sabharwal, V, Putz, O, Prins GS: Neonatal estrogen exposure induces progester­one receptor expression in the developing prostate gland. American Urologic Association, J Urology 163:97, 2000, Atlanta, GA, April 29-May 4, 2000.

88.             Habermann H,  Mehta P, Birch L, Chang W, Prins GS: Developmental exposure to estrogens alters cell adhesion and gap junction proteins in the adult prostate.  American Urologic Association, Atlanta, GA, April 29-30 J Urology 163:34, 2000.

89.             Taplin ME, Rajeskumar B, Woda B, Halabi S, Prins GS, Picus J, Hayes D, Vogelza­ng N, Small E: Androgen receptor analyses in hormone refractory prostate cancer: Cancer and Leukemia Group B (CALGB) 9663.  American Society for Clinical Oncology, New Orleans, May 20-23,  2000.

90.             Prins GS, Birch L, Couse J, Korach K: Developmental estrogenization of the prostate gland is mediated through ERa: Studies with ERKO mice.  The Endocrine Society Annual Meeting, Toronto, Canada, June 21-24, 2000.

91.             Chang WY, Bieberich C, Bhatia-Gaur R, Tebeau C, Prins, GS: Developmental estrogeniza­tion of rat prostate is associated with reductions in Hoxb-13 and Nkx3.1 homeobox gene expression. The Endocrine Society Annual Meeting, Toronto, Canada, June 21-24, 2000.

92.             Chang WY and Prins GS: Expression microarray analysis of neonatally estrogenized adult rat prostate. The Endocrine Society Annual Meeting, Toronto, Canada, June 21-24, 2000.

93.             Wang Y, Chang WY, Prins GS, van Breeman RB: Development of an LC-MS method for simultaneous determination of retinol and 9-cis, 13-cis and all-trans retinoic acid. Mass Spectroscopy Annual Meeting, 2000.

94.             Putz O, Schwartz C, Kim S, LeBlanc G, Cooper R, Prins GS: Prostatic growth response to neonatal exposure to different concentrations of 4-nonylphenol and estradiol benzoate. Gordon Research Conference on Environmental Disruptor­s, Plymouth  NH, Ju­ne 22, 2000.

95.             Prins GS: Effects of Estrogenic Exposure on Prostate Development.  American Institute for Cancer Research Annual Meeting, Washington DC, Aug 28-31, 2000, J Nutrition. 2001;131:186S‑190S.

96.             Habermann H, Mehta PP, Chang WY, Birch L, Prins GS: Connexin 43 and connexin 32 ontogeny in the rat prostate and alterations by neonatal estrogen exposure.  25th World Congress of the Societe Internationale D=Urologie, Oct 29-Nov 2, 2000, Singapore.

97.             Habermann H, Ray V, Prins GS: Connexin 43 and Connexin 32 expression in BPH and prostate cancer.  25th World Congress of the Societe Internationale D=Urologie, Oct 29-Nov 2, 2000, Singapore.

98.             Prins GS: Steroid receptors in developing prostate gland: Effects of estrogen exposure.  Hormones and Cancer 2000 Satellite Symposium, Port Douglas, Australia, Nov 3-7, 2000.

99.             Habermann H, Chang WY, Birch L, Prins GS: Ontogenese von Connexin 43 and 32 in der rattenprostata und auswirkungen von neonataler ostrogenisierung auf  Cx-expression. Duetsche Gesellschaft fur Urologie, Hamburg, Germany, Sept 30, 2000.

100.         Putz O, Schwartz C, LeBlanc GA, Cooper RL, Prins GS:  Prostatic growth response in Sprague-Dawley and Fischer 344 rats to neonatal exposure to different concentrations of estradiol benzoate.  Bisphenol A Workshop, Berlin, Germany, Nov 18-20, 2000.

101.         Moga MM, Zhou D, Geib BM, Prins GS:  Sex and species-differences in andro­gen receptor immunoreactivity in spiny lizards.  FASEB J 15:1076, March, 2001.

102.         Habermann H, Habermann W, Mehta PP, Ray V, Prins GS: Expression of Connex­in 43 (a1) and Connex­in 32 (b1) in human prostate: role in BPH and prostate cancer pathogenesi­s. European Association of Urology, Geneva, Switzerland,  April, 2001.

103.         Habermann, H, Habermann W, Ray V, Prins GS:  Gap junctions in human prostate disease.  International Society of Andrology, Montreal, Canada,  June 15-19, 2001.

104.         Woodham C and Prins GS:  Prostatic androgen receptor (AR) regulation by androgen and estrogen involves proteosome-mediated AR protein degradation. The Endocrine Society Annual Meeting, Denver CO, June 20-23, 2001.

105.         Gilleran JP, Springhart P, Birch L, Greene GL, Prins GS:  Neonatal estrogen exposure decreases ERb protein in the adult rat prostate.  American Urologic Association Annual Meeting, Orlando, FL, May 25-30, 2002.

106.         Studney P, Puccini M, Ray L, Nelson L, Niederberger C,  Ross L, Prins  GS:

Pregnancy rates with frozen TESE sperm are highly dependant on age of female partner.  American Society of Andrology Annual Meeting, Seattle, WA, April 24-28, 2002.

107.         Prins GS, Birch L, Shappell S, Couse J, Korach KS: Aging males lacking estro­gen receptor b exhibit increased prostatic lymphocytic infiltration but normal indices of prostatic proliferation in a double-blinded analysis. The Endocrine Society Annual Meeting, San Francisco, CA, June 22-24, 2002.

108.         Bianco JB, Wang H, Pedersen JS, Prins GS, Simpson ER, Risbridger GP:  Development of aggressive prostatic hyperplasia following neonatal estrogenizat­ion of the ArKO mouse.  7th International Congress on Hormones and Cancer, Fukuoka, Japan, Oct 21-25, 2002.

109.         Gilleran J, Putz O, Prins GS: The role of prolactin in neonatal estrogen imprinting of the rat prostate.  Society for Basic Urologic Research Fall Meeting, Tucson, AZ, Dec 2-5, 2002.


110.         Prins GS:  Differential gene expression in the estrogenized rat prostate.  Society for Basic Urologic Research Fall Meeting, Tucson, AZ, Dec 2-5, 2002.

111.         Gilleran J, Putz O, Prins GS: Prostatitis induced by early estrogenic exposure in the rat is partially blocked by prolactin suppression. J Urol Suppl 169: p280, American Urologic Associat­ion Annual Meeting, Chicago, IL, April 29, 2003.

112.         Pu Y, Huang L, Birch L, Prins GS: Sonic Hedgehog-Ptc-Gli signaling in develop­ing rat prostate and lobe-specific suppression by neonatal estrogens.  The Endocrine Society 85th Annual Meeting. Philadelphia, June 19-23, 2003.

113.         Pu Y, Deng L, Davies PJP, Prins GS: Retinoic acid metabolizing enzymes, binding proteins and RXRs are differentially expressed in the developing and adult rat prostate lobes and are altered by neonatal estrogens in a lobe-specific manner. The Endocrine Society 85th Annual Meeting. Philadelphia, June 19-23, 2003.

114.         Huang L, Pu Y, Alam S, Prins GS: Neonatal estrogen exposure disrupts prostate morphogenesis through alterations in BMP-4, BMP-7 and FGF-10 expression.   The Endocrine Society 85th Annual Meeting. Philadelphia, June 19-23, 2003.

115.         Birch L and Prins GS: Neonatal estrogens induce epithelial apoptosis in the developing rat prostate through inhibition of the PI3K-Akt pathway. The Endo­crine Society 85th Annual Meeting. Philadelphia, June 19-23, 2003.

116.         Prins GS: Estrogens and Prostate Development & Carcinogenesis.   The Endocrine Society 85th Annual Meeting. Philadelphia, June 19-23, 2003.

117.         Winston N, Puccini M, Studney P, Prins GS, Ross L, Nelson L: Factors predictive of successful outcome in IVF cycles utilizing cryopreserved TESE sperm.  American Society of Reproductive Medicine Annual Meeting, San Antonio, TX, Oct 2003.

118.         Alam S, Huang L, Pu Y, Prins GS: Neonatal estrogen exposure disrupts prostate morphogenes­is through alterations in BMP-4 and FGF-10 expression. American Urologic Association Annual Meeting, San Francisco, CA, May 8-12, 2004.

119.         Pu Y, Huang L, Prins GS: Neonatal estrogen exposure alters epithelial differentiation in rat prostate through down regulation of Hoxb-13. American Society of Andrology Annual Meeting, Baltimore, MD, April 17-21, 2004.

120.         Wang Z, Unterman TG, Coschegano KT, Kopchick JJ, Green JE, Prins GS, Swanson SM: Disruption of growth hormone signaling substantially retards prostate carinogenes­is in a descendant of the C3(1)/Tag transgenic mouse model.  AACR Annual Meeting, Abstract #4297, Orlando, FL, March 30, 2004.

121.         Vogelzang NJ, Waldman F, Dreicer R, Carey T, Leibert M, Leiberman R, Prins GS, Ratliff T, Simons V, Smith J, Soule H, Van Auken W, deKernion J, Roach M, Bertram K,  Giambarresi L, Mishra NC, Bisceglio I, and Bernard J:  A 6-year Analysis of the Clinical Trials (CTs) Awarded Through the Department of Defense (DOD) Congressionally Directed Medical Research Program (CDMRP) Prostate Cancer Research Program (PCRP).   Am Soc Clinical Oncology, 2005.

122.            Simons V,  Vogelzang NJ, Waldman F, Dreicer R, Carey T, Leibert M, Leiberman R, Prins GS,  Ratliff T, Smith J, Soule H, Van Auken W,  deKernion J,  Roach M III,  Miller D,  Bertram K,  Giambarresi L,  Terry-Koroma B,  Mishra NC,  Bisceglio B,  Bernard J, and  Pisha E:            Bridging the Gap: Health Disparity Research Initiatives Through the Department of Defense (DOD) Congressionally Directed Medical Research Program (CDMRP) Prostate Cancer Research Program (PCRP). AACR Annual Meeting, 2005.

123.    Carey TE, Vogelzang NJ, Waldman F, Dreicer R,  Leibert M, Leiberman R, Prins GS,  Ratliff T, Smith J, Soule H, Van Auken W,  deKernion J,  Roach M III, Simons V, Miller D,  Bertram K,  Giambarresi L,  Mishra NC,  Bisceglio B,  Bernard J, and Florence B:  A Five year analysis of the New Investigator Award Mechanism of the Department of Defense (DOD) Congressionally Directed Medical Research Program (CDMRP) Prostate Cancer Research Program (PCRP). AACR Annual Meeting, 2005.